1. Consider reduced dosage due to slower metabolism and increased sensitivity in elderly.
2. Check for potential interactions with existing medications, as polypharmacy increases risks.
3. Assess cognitive function; diphenhydramine may worsen existing confusion or cause delirium.
4. Evaluate renal function; impaired kidneys can lead to higher drug levels and toxicity.
5. Monitor for anticholinergic effects such as dry mouth, constipation, and urinary retention.

Diphenhydramine, an antihistamine, may reduce the effectiveness of allergy immunotherapy by masking symptoms rather than mitigating the allergic response itself. It’s typically advised to avoid antihistamines like diphenhydramine right before immunotherapy sessions to ensure accurate allergy testing and treatment response assessment.

Diphenhydramine can pose risks for elderly patients, including severe sedation and falls. It’s crucial to start with low doses, monitor closely for adverse effects, and review concurrent medications to avoid interactions.

Diphenhydramine should be used cautiously in the elderly due to increased sensitivity to its sedative effects, risk of confusion, and fall potential. Always check for drug interactions and adjust dosages carefully.

For elderly patients, diphenhydramine may lead to heightened side effects such as sedation and dizziness, raising fall risk. It’s important to evaluate this alongside any existing medications to prevent harmful interactions.

Elderly individuals may face elevated risks of confusion and falls with diphenhydramine. Low doses are advisable, and continuous monitoring for adverse reactions is essential to ensure safety.